Aftertrade Broking Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13, 14 and 15(1) and other ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.2 pts more than Nifty Microcap 250 and 5.4 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
A group of 5 acquirers — Mr. Arvind Karsandas Bhanushali, Mrs. Deepali Arvind Bhanushali, Mr. Jay Arvind Bhanushali, Mr. Nikunj Velji Mange, and Mr. Raj Arvind Bhanushali — along with PAC Mrs. Shraddha Nikunj Mange, have made a Public Announcement to acquire up to 26,76,180 equity shares (26% of paid-up capital) of Aspira Pathlab & Diagnostics Ltd from public shareholders. The offer price is Rs. 55 per share, taking the total deal value to approximately Rs. 14.72 crore if fully subscribed. The acquirers are mostly members of the existing promoter/promoter-group family, suggesting this is a consolidation of promoter holdings. Aftertrade Broking Pvt Ltd is managing the offer. The acquirers have stated they do not intend to delist the company.
Public shareholders can tender their shares at Rs. 55 per share in cash. Since most acquirers are existing promoters, this looks like an internal family shareholding consolidation rather than a change-of-control event, so the stock is unlikely to see major re-rating from this offer.